Align Technology Inc Quick Ratio (ALGN) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Align Technology inc   (NASDAQ: ALGN)

Align Technology Inc 's Quick Ratio

ALGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.55 below Align Technology Inc average.

Within Medical Equipment & Supplies industry 143 other companies have achieved higher Quick Ratio than Align Technology Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2196 to 2368.

Explain Quick Ratio?
How much Cash & cash equivalents ALGN´s has?
What are ALGN´s Current Liabilities?




ALGN Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 35.98 % 29 % 36.34 % 29.69 % -2.74 %
Y / Y Cash & cash equivalent Change 22.35 % 21.4 % 4.89 % -3.58 % 15.22 %
Quick Ratio MRQ 0.55 0.56 0.55 0.51 0.61
ALGN's Total Ranking # 2368 # 2196 # 1843 # 1344 # 1908
Seq. Current Liabilities Change 4.89 % -4.97 % 1.99 % 33.77 % -0.49 %
Seq. Cash & cash equivalent Change 4.03 % -3.2 % 8.99 % 11.48 % 3.22 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 144
Healthcare Sector # 726
Overall Market # 2368


Quick Ratio Statistics
High Average Low
7.05 1.54 0.38
(Sep 30 2010)   (Jun 30 2024)




Financial Statements
Align Technology Inc 's Current Liabilities $ 1,999 Millions Visit ALGN's Balance sheet
Align Technology Inc 's Cash & cash equivalent $ 1,103 Millions Visit ALGN's Balance sheet
Source of ALGN's Sales Visit ALGN's Sales by Geography


Cumulative Align Technology Inc 's Quick Ratio

ALGN's Quick Ratio for the trailling 12 Months

ALGN Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 32.73 % 22.95 % 14.37 % 1.49 % -5.88 %
Y / Y Cash & cash equivalent TTM Growth 10.41 % 8.54 % 2.84 % 2.21 % -3.06 %
Quick Ratio TTM 0.54 0.55 0.56 0.6 0.65
Total Ranking TTM # 4034 # 3199 # 2140 # 3048 # 3103
Seq. Current Liabilities TTM Growth 7.2 % 6.19 % 8.37 % 7.59 % -0.69 %
Seq. Cash & cash equivalent TTM Growth 4.96 % 4.82 % 1.33 % -0.97 % 3.18 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $1,999.05 millions, cumulative Quick Ratio decreased to 0.54 below the Align Technology Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Align Technology Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3199 to 4034.

Explain Quick Ratio?
How much Cash & cash equivalents ALGN´s has?
What are ALGN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 902
Within the Market # 4034


trailing twelve months Quick Ratio Statistics
High Average Low
2.56 0.87 0.44
(Jun 30 2011)   (Sep 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions
Pavmed Inc   1.00 $ 4.070  Millions$ 4.088  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 5.338  Millions$ 5.447  Millions
Nuwellis Inc   0.98 $ 3.922  Millions$ 4.008  Millions
Electrocore Inc   0.97 $ 11.543  Millions$ 11.933  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.96 $ 10.924  Millions$ 11.366  Millions
Medline Inc   0.96 $ 2,677.000  Millions$ 2,803.000  Millions
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions
Haemonetics Corporation  0.85 $ 223.384  Millions$ 263.235  Millions
Lifeward ltd   0.85 $ 9.448  Millions$ 11.159  Millions
Qhslab Inc   0.84 $ 0.317  Millions$ 0.376  Millions
Intelligent Bio Solutions Inc   0.84 $ 4.141  Millions$ 4.935  Millions

Date modified: 2026-09-12T18:11:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.